iShares Health Innovation Active ETF
BMEDNYSEARCABlackRockEquity
As of Oct 16, 2026 close
- Assets (AUM)
- $13.51M
- Expense ratio
- 0.55%
- Dividend yield
- 0.23%
- Holdings
- 60
- 52-week range
- $27.25$34.98
- Volume (live)
- -
- Avg. volume (3M)
- 2.11K
BMED ETF: iShares Health Innovation Active ETF - Price, Holdings & Analysis
iShares Health Innovation Active ETF Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
| Day's Range | $34.50 - $35.10 |
|---|---|
| 52-Week High | $34.98 |
| 52-Week Low | $27.25 |
| Open | $35.10 |
| Volume (last close) | 2.11K |
| Average Volume (3M) | 2.11K |
| 1 Day Change | +1.71% |
|---|---|
| 1 Month Change | +2.61% |
| 6 Month Change | +18.82% |
| YTD Change | +15.52% |
| 1 Year Change | +25.23% |
| 5 Year Change | +19.86% |
| Annual Dividend | $0.08 |
|---|---|
| Dividend Yield | 0.23% |
| Last Dividend Ex-Date | Jun 15, 2026 |
| Assets (AUM) | $13.51M |
|---|---|
| Expense Ratio | 0.55% |
| Total Holdings | 60 |
| Inception Date | Sep 28, 2020 |
| 50-Day MA | $33.69 |
|---|---|
| 200-Day MA | $30.68 |
| RSI | 55.18 |
| Stochastic %K | 72.24 |
| Stochastic %D | 57.92 |
Source: Exchange price data and fund disclosures. Data as of Oct 16, 2026. Data sources and methodology
BMED at a Glance
iShares Health Innovation Active ETF (BMED) is an equity ETF from BlackRock, launched in September 2020. It manages $13.51M in assets and charges a 0.55% expense ratio, about $55 a year per $10,000 invested.
As of its Oct 4, 2026 holdings, it holds 60 positions. The largest are Gilead Sciences, Inc (GILD, 5.08%), Danaher Corporation (DHR, 5.07%) and Merck & Co., Inc (MRK, 4.96%). The top 10 holdings make up 45.2% of the fund. By sector it leans toward Healthcare (100.0%). Its largest country exposures are United States (82.1%), Switzerland (7.8%) and Denmark (2.4%).
It pays distributions yielding 0.23% at the Oct 16, 2026 close, $0.08 per share over the trailing 12 months. As of the Oct 16, 2026 close, the share price is up 25.2% over one year and up 19.9% over five years (price change, excluding distributions).
Frequently Asked Questions About iShares Health Innovation Active ETF
What is the current price of BMED?
The latest BMED price is $34.55 (Oct 16, 2026 close). The 52-week range is $27.25–$34.98. The share price is up 25.2% over the past year (price change, excluding distributions).
What is the expense ratio for BMED?
BMED's annual expense ratio is 0.55%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does BMED pay dividends?
Yes, BMED pays a 0.23% dividend yield (trailing 12 months, at the Oct 16, 2026 close). The most recent ex-dividend date was June 15, 2026. View full dividend history in the Dividends section.
What are the top holdings of BMED?
As of Oct 4, 2026, BMED's largest holdings are Gilead Sciences, Inc (5.1%), Danaher Corporation (5.1%), Merck & Co., Inc (5.0%) (combined weight: 15.1%). The fund holds 60 total positions. View the complete portfolio breakdown in the Holdings section.
How does BMED compare to similar ETFs?
Compare BMED (0.55% expense ratio, $14M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.